Takeda Pharmaceutical Company Limited Logo
2016-01-12 17:00
Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
OSAKA, JAPAN--(Business Wire/Korea Newswire) January 12, 2016 -- Takeda Pharmaceutical Company Limited (TOKYO: 4502) (http://goo.gl/eX9kbP) (“Takeda”) today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, at the 34th Annual J.P. Morgan Healthcare Conference held in San Francisco, California. The presentation will be followed by a Q&A session.

Details of the timing, and how to access the audio webcast and presentation materials, are as follows.

Date and time
Tuesday January 12, at 11:30am - 12:30pm (Pacific Standard Time)
[Wednesday January 13, at 4:30am - 5:30am (Japan Standard Time)]

Agenda
· Presentation (25 minutes): Takeda Strategic Update
Christophe Weber, President and Chief Executive Officer
(Note: Includes updates on ENTYVIO® sales from Oct-Dec 2015, and Takeda's direction in R&D)

· Q&A session (25 minutes)
Christophe Weber, President and Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Rudolf van Houten, acting Chief Financial Officer
Christophe Bianchi, President, Global Oncology Business Unit

Access to audio webcast
http://bit.ly/1TH6bTS
· Registration is required in advance, so please visit the URL a few minutes before the presentation is scheduled to begin.
· In addition to a live webcast, the audio will also be available on-demand at this URL for 90 days following the event.

Access to presentation materials
Presentation materials will be uploaded to Takeda's website at the same time as the presentation begins:
http://bit.ly/1O6KRFX

Note: Audio and materials are available only in English.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda (TOKYO: 4502) (http://goo.gl/eX9kbP) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160107006438/en/
Takeda Pharmaceutical Company Limited 전체 보도자료 보기
이 뉴스는 기업·기관이 발표한 보도자료 전문입니다. 언론 매체와 블로그는 보도를 목적으로 이 보도자료를 사용할 수 있습니다. 보도자료 등록 안내
Media Contact

Takeda Pharmaceutical Company Limited

Media Contacts:
Tsuyoshi Tada
+81 3-3278-2417
tsuyoshi.tada@takeda.com

Investor Contacts:
Noriko Higuchi
+81 3-3278-2306
noriko.higuchi@takeda.com

이 보도자료 관련 분야

건강  제약  행사  해외

관심 분야 보도자료 구독 방법

가입하면 관심 분야 보도자료를 마이 뉴스와 이메일로 볼 수 있습니다. 스마트폰과 RSS로도 가능합니다.

보도자료 배포 서비스 안내

뉴스와이어는 4천여개 언론매체에서 일하는 1만7천여명의 기자에 보도자료를 배포해 언론이 보도할 수 있게 합니다.

해외 보도자료 배포 안내
비즈니스와이어와 제휴해 해외 언론에 보도자료를 배포합니다.